MyFinsight
Home
Blog
About
Contact
Sales of
available-for-sale debt securities
$1,307,900K
Net income
$274,900K
Net unrealized
losses on equity...
-$61,600K
Accounts receivable
-$38,200K
Share-based compensation
expense
$33,900K
Other
-$32,000K
Other assets and
liabilities
-$27,000K
Maturities of
available-for-sale debt securities
$269,000K
Deferred income taxes
$25,900K
Depreciation and
amortization
$22,600K
Net cash provided by
(used in) investing...
$743,700K
Net cash provided by
operating activities
$463,300K
Canceled cashflow
$833,200K
Canceled cashflow
$52,800K
Net (decrease)
increase in cash and cash...
-$277,400K
Canceled cashflow
$1,207,000K
Proceeds from the
exercise of stock options
$68,300K
Proceeds from the
issuance of stock under...
$5,600K
Purchases of
available-for-sale debt securities
$701,700K
Purchases of property,
plant, and equipment
$100,800K
Purchase of investment in
privately held company
$25,000K
Deposits
$5,700K
Inventories
$40,100K
Accounts payable and
accrued expenses
-$12,700K
Net cash used in
financing activities
-$1,484,400K
Canceled cashflow
$73,900K
Payments to repurchase
common stock
$1,500,000K
Rsus withheld for
taxes
$58,300K
Back
Back
Cash Flow
UNITED THERAPEUTICS Corp (UTHR)
UNITED THERAPEUTICS Corp (UTHR)
source: myfinsight.com